Table 1. Experimental Study Table.
| Sample ID | Tumor Type | Protocol 1 | Protocol 2 | Protocol 3 | Study Accession Number * | Dataset Accession Number * |
|---|---|---|---|---|---|---|
| 42470 | HGSC† | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 42474 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 42478 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 40-05 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 47-05 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 64-05 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 74-05 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 76-05 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 105-06 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 106-06 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 109-06 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 94-06 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 99-06 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 123-07 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 133-07 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 156-07 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 157-07 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 198-08 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 206-08 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 230-08 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 237-08 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 309-09 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 337-09 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 353-09 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 381-09 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 416-09 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 466-10 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 471-10 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 472-10 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 490-10 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 497-10 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 521-10 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 531-10 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 537-10 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 543-10 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 565-10 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 568-10 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 586-11 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 612-11 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 614-11 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 630-11 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 631-11 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 634-11 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 638-11 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 651-11 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 666-11 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 676-11 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 679-11 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 694-11 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 702-11 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 711-11 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 764-12 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 767-12 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 778-12 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 787-12 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 849-13 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 862-13 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 879-13 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 880-13 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 938-13 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 943-13 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 949-13 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 958-13 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 1001-14 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 1004-14 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 966-14 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 969-14 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 985-14 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 881-13 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 695-11 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 493-10 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 427-09 | HGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 544-10 | LGSC‡ | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 624-11 | LGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 909-13 | LGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
| 730-12 | LGSC | Tumor DNA extraction | Fluidigm Access Array™ BRCA1/BRCA2/TP53 | Massively Parallel Sequencing (MiSeq) | EGAS00001002200 | EGAD00001003119 |
*Data can be accessed through the European Genome-phenome Archive (EPA).
†human high-grade serous ovarian cancer.
‡human low-grade serous ovarian cancer.